Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Infectious Diseases

Infectious Diseases: market research reports

Infectious Diseases market research reports and industry analysis

Community-Acquired Infections – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Community-Acquired Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community-Acquired Infections. Community-Acquired Infections - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Seasonal Influenza – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Seasonal Influenza, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Seasonal Influenza. Seasonal Influenza - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Ventilator Associated Pneumonia (VAP) – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ventilator Associated Pneumonia (VAP). ... \| read more...	$2,000.00
Measles – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Measles. Measles - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Ebola Viral Infections – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... development for Ebola Viral Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ebola Viral Infections. Ebola Viral Infections - ... \| read more...	$2,000.00
Competing in the Japanese Infectious Disease Testing Market 2/22/2013 \| published by: Venture Planning Group ... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Five-year test volume ... \| read more...	$8,800.00
Competing in the Global Respiratory Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players 2/22/2013 \| published by: Venture Planning Group ... of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are ... \| read more...	$9,850.00
Infectious Diseases Point of Care Diagnostics - Products, Players and Outlook to 2017 2/20/2013 \| published by: Espicom Healthcare Intelligence The market for Point-of-Care (POC) diagnostic products used in infectious diseases is expected to exceed US$1.8 billion by 2017, with year-on-year double digit growth from 2013 onwards. \| read more...	$1,390.00
Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019 1/25/2013 \| published by: GlobalData ... is an essential source of information and analysis on the global Cytomegalovirus (CMV) Infections Therapeutics market. The report identifies the key trends shaping and driving the global Cytomegalovirus (CMV) Infections Therapeutics market. The report also ... \| read more...	$5,995.00
Competitive Intelligence: Leading Infectious Disease Market Players--Insightful Profiles of Major Suppliers and Emerging Market Entrants 1/22/2013 \| published by: Venture Planning Group ... emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 90 pages Please note : The delivery ... \| read more...	$1,850.00
Competitive Intelligence: Leading Infectious Disease Market Players-Insightful Profiles of Major Suppliers and Emerging Market Entrants 1/22/2013 \| published by: Venture Planning Group ... emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 90 pages Please note: The delivery time ... \| read more...	$1,850.00
The 2013-2018 World Outlook for Influenza Vaccines 1/7/2013 \| published by: Icon Group International, Inc. ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to ... \| read more...	$795.00
The 2013-2018 World Outlook for Pharmaceutical Preparations for Human Use Affecting Parasitic and Infectious Diseases Excluding Diagnostics 1/7/2013 \| published by: Icon Group International, Inc. ... infectious diseases excluding diagnostics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... \| read more...	$795.00
Infection Control in Ambulatory Care 1/1/2013 \| published by: Apollo Managed Care, Inc. ... meet OSHA, Joint Commission, NCQA and other standards for accreditation and certification visits in a medical office or an ambulatory care setting. Resources include forms, OSHA standards, Surgical safety checklist; web links, references. Updated annually. \| read more...	$129.00
Plague – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Plague. Plague - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Community Acquired Bacterial Pneumonia – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... the therapeutic development for Community Acquired Bacterial Pneumonia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community Acquired Bacterial Pneumonia. ... \| read more...	$2,000.00
Community Acquired Pneumonia – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... development for Community Acquired Pneumonia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Community Acquired Pneumonia. Community Acquired Pneumonia - ... \| read more...	$2,000.00
Bacterial Infections – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacterial Infections. Bacterial Infections - Pipeline Review, Half Year is ... \| read more...	$2,000.00
H5N1 Infection (Avian Influenza) – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... the therapeutic development for H5N1 Infection (Avian Influenza), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H5N1 Infection (Avian Influenza). ... \| read more...	$2,000.00
Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Streptococcus Pneumoniae (Pneumococcus) Infections. ... \| read more...	$2,000.00
Gram-Negative Bacterial Infections – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... development for Gram-Negative Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gram-Negative Bacterial Infections. Gram-Negative Bacterial Infections - ... \| read more...	$2,000.00
2013 Influenza Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country 12/24/2012 \| published by: Venture Planning Group ... epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health ... \| read more...	$3,850.00
Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes 12/14/2012 \| published by: GBI Research ... report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to ... \| read more...	$3,500.00
Getting Social With Disease: How Public Health Authorities in Central and Eastern Europe can Improve Outbreak Predictions with Social Media 12/11/2012 \| published by: IDC ... whether something "small" like an off-the-shelf analytics application or "large" like a full-scale migration of systems and software to a cloud-based delivery model. Usually this is okay. But in the realm of public health, it ... \| read more...	$1,500.00
Forecast: Pneumococcal Vaccines 12/5/2012 \| published by: Datamonitor ... from 2012 to 2021. Vaccination coverage rates, pricing, dosing, and future event assumptions are added to create Datamonitor's forecast. Features and benefits Provides detailed sales forecasts for each of the seven major markets based on ... \| read more...	$11,400.00

< prev 1 2 3 4 5 6 7 8 9 10 next >